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http://dx.doi.org/10.1016/j.pedneo.2Objectives: We examined correlations between the two asthma assessment tools, pulmonary
function tests, and Childhood Asthma Control Test (C-ACT) scores, in 5e11-year-old children
with asthma to determine if the C-ACT scores could predict pulmonary function test results.
Materials and methods: A total of 172 children with asthma aged 5e11 years completed C-ACT
questionnaires and underwent pulmonary function testing. Correlations between these test re-
sults were examined. Patients were also placed into two groups, C-ACT scores 19 and >19, to
determine if patients with scores >19 had better pulmonary function test results.
Results: Weak correlations were found between pulmonary function test results and childhood
asthma control test scores in 5e11-year-old children with asthma, with or without the use of
an asthma controller. These correlations included: 0.061 for FEV1 [confidence interval (CI):
0.022e0.049] and 0.074 for MMEF (CI: 0.013e0.037). The proportions of children with
C-ACT test scores 19 group and those with scores >19 group were not significantly different.spiratory Therapeutic Unit, Changhua Christian Hospital, Changhua, 135 Nanxiao Street, Changhua
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spirometryConclusion: Correlations between C-ACT scores and pulmonary function test results were poor
for children aged 5e11 years with asthma. FEV1, FVC, FEF25, FEF50, FEF75, MMEF, and PEFR
were not significantly correlated with C-ACT scores.
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reserved.1. Introduction
Childhood asthma is a common chronic disease that can be
fatal in critical conditions without timely treatment. In
recent years, asthma treatment has emphasized both the
severity of an attack and the degree of asthma control that
can be achieved. The Childhood Asthma Control Test (C-
ACT) is a widely used asthma control assessment tool that is
recognized by the Global Initiative for Asthma (GINA). This
assessment questionnaire was developed by Liu et al1 in
2007 for children aged 4e11 years with asthma.
This questionnaire includes seven questions and is
divided into two parts: the first four questions are self-
administered by the child; the last three questions are
answered by a caregiver on the basis of the child’s condi-
tion during the previous 4 weeks. The total Asthma Control
Test score is the sum of the answers given by the children
and caregivers. Scores of 20 indicate good asthma con-
trol, whereas scores of 19 indicate inadequate asthma
control in children. The results of this questionnaire were
highly correlated with specialists’ ratings of asthma control
and the need for changes in patients’ therapies
(p < 0.0001).1
Lung function tests are used for pediatric asthma pa-
tients to examine changes in lung volume and air flow
during forced inspiration and expiration in order to deter-
mine the degree of airway obstruction. Pediatric patients
must be older than 5 years of age to undergo a lung function
test. The most commonly used parameters include peak
expiratory flow rate (PEFR), forced vital capacity (FVC),
forced expiratory volume in the first second (FEV1), FEV1/
FVC ratio, forced expiratory flow at 25% of forced vital
capacity (FEF25), forced expiratory flow at 50% of forced
vital capacity (FEF50), forced expiratory flow at 75% of
forced vital capacity (FEF75), the ratio between forced
expiratory flow between 25% and 75% of vital capacity
(FEF25e75), and the maximal mid-expiratory flow rate
(MMEF), which indicates the average expiratory flow over
the middle half of the forced vital capacity. FEF25, FEF50,
FEF75, FEF25e75, and MMEF are useful for detecting small
airway obstruction, and MMEF and FEF50 are highly
correlated.2,3
In addition, currently used lung function devices also
calculate the percentages of the predicted values for FEV1,
FEF25, FEF50, FEF75, MMEF, FVC, and PEFR. For example, the
percent predicted FEV1 (FEV1 % predicted) is defined as the
patient’s FEV1 divided by the average FEV1 in a population
of similar age, sex, and body composition.
Clinically, the vast majority of children with asthma who
receive long-term medication treatment do not present
decreases in FEV1 or FEV1/FVC without an asthma attack;
only abnormal decreases in FEF25, FEF50, FEF75 or MMEF arenoted. These pulmonary function results indicate that the
vast majority of children with asthma only have a small
airway obstruction. The study by Liu et al1 showed that C-
ACT scores and FEV1 % predicted values were weakly
correlated (p Z 0.0494). Previous studies investigated
correlations between C-ACT scores and PEFR results.1,4,5
However, correlations between C-ACT scores and FEF25,
FEF50, FEF75, and MMEF have not been investigated.
Thus, in this study, we examined the correlations be-
tween two asthma assessment tools, pulmonary function
test results for FEV1, FVC, FEF25, FEF50, FEF75, MMEF, and
PEFR, and C-ACT scores. Our aim was to determine if C-ACT
scores could predict the pulmonary function results for
young asthma patients and to help clinicians have better
understanding and control childhood asthma without acute
attacks.
2. Materials and Methods
2.1. Study patients
This study was conducted from December 30, 2011 to
December 29, 2012 in Changhua Christian Hospital, Chan-
ghua, Taiwan. The participants were 5e11-year-old pa-
tients with asthma who were undergoing routine clinic
follow-ups and required pulmonary function tests. All pa-
tients had more than three asthma episodes that had been
diagnosed by the same attending physician; the interval
between diagnoses was more than 1 month. Some patients
with a diagnosis of asthma were still using a controller
(leukotriene antagonist or inhaled corticosteroid), whereas
others were stable and had stopped using a controller.
We excluded patients with pulmonary or upper respira-
tory infections or those having acute asthma attacks. Pa-
tients who had taken theophylline, beta agonist within
1 day or steroid within 3 days, were also excluded from this
study in order to avoid the effects of medication on the
pulmonary function. We recorded and grouped patients by
their current medication use; patients who were using an
inhaled corticosteroid or a leukotriene antagonist (Singu-
lair) were the controller group and patients who had
stopped using these two medications were the non-
controller group. This study was approved by the Institu-
tional Review Board of Changhua Christian Hospital.
2.2. C-ACT questionnaires
We provided the C-ACT questionnaire 10 minutes prior to
when a patient underwent pulmonary function testing.
Primary information about the study was presented to both
the relatives and the child by a respiratory therapist. Once
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individually. Relatives were allowed to make a phone call to
other caregivers if he or she were not sure about the
answer. For the children who could read, the respiratory
therapist were trained to provide consist help and detailed
clarifications. Questionnaires were filled on the basis of
subjective findings and then collected by the respiratory
therapist after completion.
2.3. Lung function testing
Lung function test results had tomeet the American Thoracic
Society criteria. We excluded patients for poor effort if they
were younger than 10 years of age and exhaled for less than
3 seconds or if they were older than 10 years of age and
exhaled for less than 6 seconds. Each child had to have at
least three reproducible results and the best data were
chosen for comparisons with standard reference values. The
testing sessions were limited to 15 minutes.6,7
We used a MasterScreen Body/diffusion pulmonary
function device manufactured by JAEGER (Hoechberg,
Germany). The normal reference values for children’s pul-
monary function were based on data published by Zapletal
in Europe for Caucasians (age range: 4e18 years; height
range: 115e180 cm).8 We defined the following as normal
values: FEV1/FVC  80%; PEFR, FEV1  80% compared to
normal reference values; FEF25, FEF50, FEF75, and
MMEF  56% compared to normal reference values.
Currently, there are no reference data in Taiwanese
children and racial differences may exist. We tried to
overcome this problem by adjusting the cutoff value of the
normal reference. We gave two more cutoff values for
FEV1, FEV1/FVC, and PEFR (70% and 90% of predicted), and
three more cutoff values for FEF25, FEF50, FEF75, and MMEF
(50%, 60% and 65% of predicted).
2.4. Statistical analysis
Patients’ basic data, including age, sex, body weight, and
body height, were recorded. Results for demographic var-
iables, pulmonary function test results, and C-CAT scores
are given as mean and standard deviations. As appropriate,
Student t test or Mann-Whitney U test was used to compare
group results for continuous variables. Results for cate-
gorical variables were compared using the Chi-square test
or Fisher’s exact test. After adjusting for age, height, sex,
body mass index, and the use of a controller, multivariate
linear regression was used to determine correlations be-
tween the C-ACT scores and the pulmonary function values.
Correlation coefficients between the C-ACT scores and the
pulmonary function values and the corresponding confi-
dence intervals were determined. A p value <0.05 was
considered significant.
3. Results
A total of 172 patients were recruited for this study from
July 2011 to July 2012. Their mean age was 8.7 years, and
their mean body height was 133.2 cm. Singulair or inhaled
corticosteroids were used by the controller group (126/
172; 73.2%), and the other patients were the noncontrollergroup (46/172; 26.7%). There were 118 females (68.6%)
and 54 males (31.4%). Table 1 shows the demographic data
for patients in the controller group and noncontroller
group. There were no significant differences for height,
weight, age, or pulmonary function indices between these
two groups. The mean C-ACT scores for the controller
group and the noncontroller group were 22.8 and 23.3,
respectively; both were >19. Of 172 patients, 33 (19.2%)
had FEV1 < 80% of predicted, 63 (36.6%) had FEV1/
FVC < 80%, 112 (65.1%) had FEF25, FEF50, FEF75, or
MMEF < 56% of predicted.
Table 2 shows comparisons between the different pul-
monary function results based on the proportions of pa-
tients with C-ACT scores 19 and the proportions of
patients with C-ACT scores >19. Statistically speaking,
none of the pulmonary function results were significantly
different in terms of the proportions of patients with C-ACT
scores 19 and patients with C-ACT scores >19. In Table 2,
the pulmonary function test result that was closest to sta-
tistical significance was MMEF < 56% of predicted; the
proportion of patients with C-ACT scores 19 was higher
than the proportion of patients with C-ACT scores >19 (56%
vs. 36.1%, p Z 0.059). Another test near statistical signifi-
cance was FEF75 < 56% of predicted, the proportion of
patients with C-ACT scores 19 was higher than the pro-
portion of patients with C-ACT scores >19 (20% vs. 7.6%,
p Z 0.061).
Even though we gave two more cutoff values for FEV1,
FEV1/FVC, and PEFR in Table 2 (70% and 90% of predicted),
there were still no significant correlation between lung
function tests and C-ACT scores after the Chi-square test or
Fisher’s exact test. When giving three more cutoff values
for FEF25, FEF50, FEF75, and MMEF in Table 2 (50%, 60%, and
65% of predicted), we found that only in the cutoff value of
60, FEF75 correlates with the C-ACT scores. FEF75 less than
60% of predicted had a higher rate of C-ACT scores <19
(31.8% vs 12.0%, p Z 0.014).
Multivariate linear regression analysis results adjusted by
age and height showed that the correlations between C-ACT
scores and pulmonary function values were poor. The cor-
relation coefficient for FEV1 was 0.061 (CI: 0.022e0.049)
and the one for MMEF was 0.074 (CI: 0.013e0.037).
Table 3 shows comparisons between different pulmonary
function results and C-ACT mean scores. When patients
with FEV1 < 70% of predicted were compared with patients
with 70% of predicted, the mean total score for patients
with FEV1 < 70% of predicted was 21.6 and the mean total
score of patients with FEV1  70% of predicted was 23.2;
these were not significantly different (p Z 0.158). We also
compared children’s scores and parents’ scores for these
FEV1 results; the children’s scores were statistically signif-
icant (p Z 0.019), whereas the parents’ scores were not
(p Z 0.966).
When patients were grouped into FEV1 < 80% and
FEV1  80% of predicted, the total scores were not signifi-
cantly different. Children’s scores and parents’ scores were
also not statistically significant (p Z 0.213 and p Z 0.939,
respectively). Similarly, for patient groups of FEF25, FEF50,
and FEF75  56% of predicted and FEF25, FEF50, and
FEF75 < 56% of predicted, there were no statistically sig-
nificant differences when comparing the mean total C-ACT
scores.
Table 1 Demographic data for patients with and without controller use.*,y
Controller use p
No (n Z 46) Yes (n Z 126)
Mean SD Median Min Max Mean SD Median Min Max
Age 8.8 2.2 9.2 5 11.8 8.7 1.9 8.7 5.2 11.9 0.842
Weight 35.5 14.0 31.0 18.6 71.0 32.9 10.7 30.5 18.0 79.0 0.289
Height 134.6 14.0 136.8 110.0 160.0 132.7 12.3 133.0 102.0 157.0 0.397
BMI 18.9 4.2 17.4 13.0 29.0 18.3 3.5 17.8 11.6 35.1 0.393
Total score 22.8 4.0 24.0 11.0 27.0 23.3 3.2 24.0 13.0 27.0 0.361
Child score 10.2 2.0 11.0 3.0 12.0 10.0 1.6 10.0 6.0 12.0 0.686
Parent score 12.6 3.0 13.5 1.0 15.0 13.3 2.1 14.0 4.0 16.0 0.170
Expiratory time (s) 6.0 1.7 6.0 3.0 12.0 5.9 1.9 6.0 3.0 16.0 0.812
FVC 98.5 15.5 96.2 73.0 137.9 96.1 14.0 95.2 52.1 149.6 0.350
FEV1 92.1 17.1 89.5 57.0 137.9 90.4 15.0 88.7 44.5 151.2 0.534
FEV1/FVC 83.0 10.4 82.2 64.2 109.2 83.5 8.3 83.5 57.2 106.8 0.719
MMEF 64.7 22.7 63.7 20.3 123.1 64.5 20.6 60.2 21.9 123.5 0.961
FEF75 83.0 20.8 78.0 41.4 130.3 81.4 21.9 77.8 26.4 167.8 0.669
FEF50 67.7 23.9 64.8 20.5 127.3 68.5 21.5 65.1 21.7 144.1 0.833
FEF25 55.6 27.8 51.8 15.4 155.7 51.4 19.2 47.7 17.3 112.0 0.349
PEFR 88.6 18.0 86.4 49.9 132.7 85.8 19.7 86.4 31.1 156.1 0.388
BMIZ body mass index; FEF25Z forced expiratory flow at 25% of forced vital capacity; FEF50Z forced expiratory flow at 50% of forced
vital capacity; FEF75 Z forced expiratory flow at 75% of forced vital capacity; FEV1 Z forced expiratory volume in the 1
st second;
FVC Z forced vital capacity; MMEF Z maximal mid-expiratory flow rate; PEFR Z peak expiratory flow rate; SD Z standard deviation.
* The p values are derived from Student’s t test.
y Percentages of predicted values for FEV1, FVC, FEF25, FEF50, FEF75, MMEF, and PEFR are given.
Table 2 Comparisons of pulmonary function results for the proportions of patients with C-ACT scores  19 and the proportions
of patients with C-ACT scores > 19.*,y
% n (%) Score  19 Score > 19 p
n (%) n (%)
Total 172 (100) 25 (14.5) 147 (85.5)
FEV1/FVC <80 63 (36.6) 9 (36) 54 (36.7) 0.944
80 109 (63.4) 16 (64) 93 (63.3)
PEFR <80 62 (36) 11 (44) 51 (34.7) 0.37
80 110 (64) 14 (56) 96 (65.3)
FEV1 <80 33 (19.2) 7 (28) 26 (17.7) 0.271
80 139 (80.8) 18 (72) 121 (82.3)
FEV1 <70 9 (5.2) 2 (8) 7 (4.8) 0.620
70 163 (94.8) 23 (92) 140 (95.2)
MMEF <56 67 (39) 14 (56) 53 (36.1) 0.059
56 105 (61) 11 (44) 94 (63.9)
FEF75 <56 16 (9.3) 5 (20) 11 (7.5) 0.061
56 156 (90.7) 20 (80) 136 (92.5)
FEF50 <56 52 (30.2) 11 (44) 41 (27.9) 0.105
56 120 (69.8) 14 (56) 106 (72.1)
FEF25 <56 109 (63.4) 20 (80) 89 (60.5) 0.062
56 63 (36.6) 5 (20) 58 (39.5)
C-ACTZ Childhood Asthma Control Test; FEF25Z forced expiratory flow at 25% of forced vital capacity; FEF50Z forced expiratory flow
at 50% of forced vital capacity; FEF75Z forced expiratory flow at 75% of forced vital capacity; FEV1Z forced expiratory volume in the 1
st
second; FVC Z forced vital capacity; MMEF Z maximal mid-expiratory flow rate; PEFR Z peak expiratory flow rate.
* The p values are derived from Chi-square test or Fisher’s exact test as appropriate.
y Percentages of predicted values for FEV1, FVC, FEF25, FEF50, FEF75, MMEF, and PEFR are given.
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Table 3 Comparisons of pulmonary function results and C-ACT mean scores.*,y
% Total score Score of children Score of caregivers
Mean SD p Mean SD p Mean SD p
Total 23.2 3.4 10.1 2 13.1 2.4
FEV1/FVC <80 23 3.8 0.7 10 2 0.85 13 2.5 0.7
80 23.2 3.2 10.1 2 13.1 2.3
PEFR <80 23 3.9 0.7 10.1 2 0.92 13 2.6 0.56
80 23.2 3.1 10.1 2 13.2 2.2
FEV1 <80 22.8 4.4 0.6 9.7 2 0.21 13.1 2.7 0.94
80 23.2 3.2 10.1 2 13.1 2.3
FEV1 <70 21.6 4.1 0.2 8.6 2 0.02 13 2.8 0.97
70 23.2 3.4 10.1 2 13.1 2.3
MMEF <56 22.6 3.7 0.1 9.8 2 0.08 12.9 2.4 0.31
56 23.5 3.2 10.2 2 13.2 2.3
FEF75 <56 22.1 4.8 0.3 9.4 3 0.3 12.6 2.9 0.41
56 23.3 3.2 10.1 2 13.1 2.3
FEF50 <56 22.8 3.9 0.3 9.8 2 0.24 12.9 2.5 0.58
56 23.3 3.2 10.2 2 13.2 2.3
FEF25 <56 22.9 3.6 0.2 9.9 2 0.07 13 2.3 0.68
56 23.6 3.1 10.4 2 13.2 2.5
C-ACTZ Childhood Asthma Control Test; FEF25Z forced expiratory flow at 25% of forced vital capacity; FEF50Z forced expiratory flow
at 50% of forced vital capacity; FEF75Z forced expiratory flow at 75% of forced vital capacity; FEV1Z forced expiratory volume in the 1
st
second; FVC Z forced vital capacity; MMEF Z maximal mid-expiratory flow rate; PEFR Z peak expiratory flow rate; SD Z standard
deviation.
* The p values are derived from Student’s t test or Mann-Whitney U test as appropriate.
y Percentages of predicted values for FEV1, FVC, FEF25, FEF50, FEF75, MMEF, and PEFR are given.
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We found that the correlations between C-ACT question-
naire scores and pulmonary function results were poor.
Only MMEF and FEF75 had borderline significance in pre-
dicting C-ACT scores. Increasing patient numbers may in-
crease the significance of these two items, but they are still
poorly correlated with C-ACT scores. In the study by Liu
et al1 published in 2007, which developed the C-ACT
assessment tool, their results showed that the mean C-ACT
score of patients with FEV1 < 60% of predicted was 16.33,
and the mean C-ACT scores of patients with FEV1 of 60e79%
of predicted and 80e99% of predicted were 21.21 and
22.00, respectively. These three groups showed borderline
statistical differences (p Z 0.0494), although these dif-
ferences were mainly because of patients with FEV1 < 60%
of predicted; the difference in mean value for patients with
FEV1 > 60% of predicted was not significant. That study also
noted that for patients whose FEV1/FVC values were
grouped by < 80%, 80e99%, and 100%, their mean C-ACT
scores were not significantly different (p Z 0.1554). We
analyzed other items of pulmonary function, including
FEF25, FEF50, FEF75, and MMEF. Our results showed that C-
ACT scores and FEV1, FEV1/FVC, FEF25, FEF50, FEF75, and
MMEF values were poorly correlated.
There have been many studies on correlations between
the C-ACT scores and the pulmonary function. A study by
Yoos et al5 in 2002 suggested that PEFR results and C-ACT test
scores were not correlated; another study by Chen et al4 in
2008 that confirmed the efficacy and reliability of the Chi-
nese C-ACT questionnaire also showed poor correlation of
PEFR results and C-ACT test scores; Waibel et al9 compared amodified C-ACT and lung function test results for 85 children
in 2012. They found that the mean modified C-ACT score for
patients with FEV1 < 80% of predicted was 19.9, and the
mean modified C-ACT score for patients with FEV1  80% of
predicted was 23.1 (pZ 0.049), which showed only border-
line statistical significance. However, patients older than
12 years of age made up 47% of their study population; thus,
not all of their participants were 4e11 years old, and the C-
ACT questionnaire was designed specifically for patients
aged 4e11 years. In 2011, Ito et al10 suggested that the C-ACT
scores and FEV1 % predicted values were significantly
correlated (rZ 0.317; p < 0.001). They noted that a cutoff
value of 23 for the C-ACT could be useful for identifying
children with normal lung function. However, after we
changed our study’s C-ACT cutoff point from 19 to 23 based
on their observations, we found that 20 patients with scores
of >23 had FEV1 < 80% of predicted; the comparison with
patients with scores of <23 was not significant.
Other studies investigated correlations between clinical
asthma symptom scores and lung function test results. For
example, Ducharme et al11 published an asthma quiz for
kids for children aged 6e17 years in 2004 and also found
that its results were not correlated with spirometry results.
Similarly, Mitra et al12 proposed in 2002 that even pediatric
patients with normal lung function still could have asthma
symptoms and their lung function test results and clinical
symptoms were poorly correlated.
For adult studies, Nathan et al13 developed an adult
asthma control test in 2004 and noted that adult asthma
control test scores could discriminate between groups of
patients that differed in the FEV1 % predicted values
(p Z 0.052), although the correlation between the FEV1
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conducted a study for patients aged 12e84 years in 2006
and found that adult asthma control test scores and FEV1 %
predicted values were correlated. In their study, the same
group of patients took asthma control tests and FEV1 %
predicted tests twice at intervals of 4e12 weeks; they
found that the asthma control test scores for those with
FEV1 % predicted improved by  10% and those who
improved by <10% were significantly different.14 A study by
Chen et al15 in 2010 indicated that adult asthma control
test scores and FEV1 % predicted values were correlated.
However, in their study, FEV1 % predicted values only
explained 18.2% of the ACT scores. In addition, a study on
adult ACT by LeNoir et al16 noted that FEV1 values were not
always correlated with the level of asthma control.
Based on these studies, correlations between the
asthma control test scores and the pulmonary function test
results have not been established in adults, except for the
study results of Nathan et al13 and Schatz et al.14 However,
it was not determined whether these correlations were due
to adult patients being able to completely interpret their
symptoms or because their study method compared a pa-
tient’s FEV1% predicted and asthma control test results at
different time points. Further studies are required to
clarify these issues.
Based on the above results, we concluded that lung
function and symptoms might have different meanings for
asthma control in children aged 5e11 years. Lung function
tests reflect a patient’s respiratory tract conditions on that
day, whereas the C-ACT reflects a patient’s symptoms over
the previous month. We excluded those patients with res-
piratory tract infections and those who used bronchodila-
tors and steroids, yet the respiratory tract conditions of
patients on the test day might vary due to various factors,
such as their physical condition, psychological condition,
amount of exercise, humidity, and exposure to allergens.
Children and parents also had different explanations for
disease severity. Some children had severe conditions but
believed that they could accept them; consequently, they
would provide high C-ACT scores. In addition, some parents
may have poor memory and might forget what happened
during the previous month, so they would provide answers
based on the current conditions of patients. This would
result in poor correlations between these two tests.
Therefore, we suggest that clinicians should use these two
tools to assess the care conditions of their patients at the
same time in order to fully understand the asthma control
for patients aged 5e11 years. This may enhance the
recognition of poorly controlled asthma.
Previous studies described that children’s perspectives
were very important aside from the parents’ descriptions.
For instance with reference to Guyatt et al,17 for children
younger than 11 years old, the correlation between the
descriptions of symptoms by children and the quality of life
measures were higher than with parents’ descriptions.
Thus, the C-ACT questionnaire was divided into two parts
for children and parents. An interesting finding from our
study was when we compared patients with FEV1 < 70% of
predicted and those with FEV1  70% of predicted; the
overall scores and parents scores were not significantly
different, whereas children’s scores were statistically
significantly different (Table 3). Children with poorpulmonary function provided lower C-ACT scores when they
had pulmonary function tests.
However, some caution should be taken when inter-
preting children’s answers to C-ACT questions. There are
four questions for children in the C-ACT. Children have poor
memory regarding the past or have difficulty in rating their
conditions; therefore, they often provide extreme answers,
such as very good or very bad. Thus, when their physical
condition is poor, they would have lower scores, particu-
larly for the question “How is your asthma today?” The
results for the latter might be greatly affected. For this
reason, children’s scores that showed statistical differ-
ences might not reflect any special clinical significance.
The accuracy of the results for PEFR, FEV1, FEV1/FVC,
and FVC in pulmonary function tests depends on the effort
produced by patients during inhalation and exhalation. The
accuracy of MMEF, FEF25, FEF50, and FEF75 depends on the
accuracy of FVC.18,19 All of the patients in this study per-
formed pulmonary function testing under the guidance of a
respiratory therapist; it was emphasized that exhalation
should last for at least 3 seconds to obtain reliable values.
The demographic characteristics, C-ACT scores, and lung
function test results for the controller group and non-
controller group in this study were not significantly
different. Traditional standard treatments for asthma
control include inhaled corticosteroids or a leukotriene
antagonist. However, patients in our noncontroller group
had not received any long-term medications. This was
because the patients recruited for our noncontroller group
had routine follow-ups and stopped using these medications
after their conditions became stable. None of these pa-
tients had poor drug compliance. Thus, the demographic
characteristics were similar in these two groups.
Younger children (5e6 years old) might find hard to
reach the standard spirometry results. They sometimes
showed the result of poor effort (low FEV1% and normal
FEV1/FVC ratio), even if they meet the criteria of end of
test (over 3 seconds). In this study, there were 14 patients
who had FEV1 < 80% of predicted and FEV1/FVC > 80% of
predicted. All of these 14 children were older than
6.5 years old; their mean expiratory time lasted 6.26 sec-
onds (SD: 2.40 seconds), and the median expiratory time
lasted 6 seconds. If we exclude the 14 patients’ results and
reanalyze our data, we can find that only FEF75 correlates
with C-ACT scores. FEF75 < 56% of predicted had a higher
rate of C-ACT scores <19 (35.7% vs 12.5%, p Z 0.019).
The major limitation of our study was that most of our
cases had predicted FEV1 > 70% of predicted. Only nine pa-
tients in our study had FEV1 values of <70% of predicted,
which may have resulted in the insignificant associations
between lung function test results and C-ACT scores. How-
ever, we analyzed the data for these nine patients with
FEV1 < 70% of predicted separately; their mean C-ACT score
was 21.6, which was higher than the value that defined poor
control in the C-ACT questionnaire. Thus, we have some
doubts as towhether the C-ACTscores can accurately predict
pulmonary FEV1 results. The results of our study were in
accordance with current medical practice goals aiming for a
good control over childrenwith asthma.On follow-up testing,
FEV1 values were mostly normal. In fact, most of these chil-
dren with asthma had abnormal results only for FEF25, FEF50,
FEF75, FEF25-75, or MMEF during clinic follow-ups.
224 M.-S. Lee et alAnother limitation was that we did not use pairs of pre-
and postpulmonary function testing and C-ACT scores and
compare these correlations. In a study by Chen et al4 con-
ducted in 2008, 247 Chinese asthmatic children were
recruited to determine the correlations between C-ACT
score changes and percent predicted PEFR values for
4e8 week intervals. This showed a poor correlation
(r Z 0.097; p Z 0.44). However, their study only included
PEFR and did not analyze other pulmonary function values.
Thus, this is a future research direction.4
In conclusion, from our study results, the correlations
between C-ACT scores and pulmonary function test results
for children were poor. Pulmonary function test values for
FEV1, FVC, FEF25, FEF50, FEF75, MMEF, and PEFR were not
significantly correlated with C-ACT scores. These findings
may help clinicians better understand and control child-
hood asthma without acute attacks. If clinicians combine
the C-ACT questionnaire and lung function testing to assess
patients, they may discover more patients with inadequate
asthma control.
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